Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 337
Issue Date | Title | Author(s) |
2024-02 | Guest editorial overview: ‘Mapping the future of consumer behaviour using disruptive technologies’ | Nigam, Achint |
2024-03 | Blockchain’s double-edged sword: thematic review of illegal activities using blockchain | Nigam, Achint |
2024-12 | Dark side of the metaverse and user protection | Nigam, Achint |
2024-12 | Good governance and implementation | Nigam, Achint |
2025-03 | Exploring barriers to social robot adoption: A mixed-method study in the Indian retail sector | Nigam, Achint |
2018 | SentiCon: A Concept Based Feature Set for Sentiment Analysis | Mitra, Satanik |
2020-06 | Hybrid Improved Document-level Embedding (HIDE) | Mitra, Satanik |
2021-01 | An Approach to Identify Provocative and Problematic Content with Social Nociceptor | Mitra, Satanik |
2021-05 | Helpfulness of online consumer reviews: A multi-perspective approach | Mitra, Satanik |
2021-11 | Experiments on Fraud Detection use case with QML and TDA Mapper | Mitra, Satanik |
2022 | Suicidal Intention Detection in Tweets Using BERT-Based Transformers | Mitra, Satanik |
2022 | Sarcasm Detection in News Headlines using Supervised Learning Publisher: IEEE PDF | Mitra, Satanik |
2020-06 | OBIM: A computational model to estimate brand image from online consumer review | Mitra, Satanik |
2014 | Effects of adhatoda vasica leaf extract in depression co‑morbid with alloxan‑induced diabetes in mice | Mahesh, R. |
2012-06 | Ligand-Based Design, Synthesis, and Pharmacological Evaluation of 3-Methoxyquinoxalin-2-carboxamides as Structurally Novel Serotonin Type-3 Receptor Antagonists | Mahesh, R. |
2013 | Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety | Mahesh, R. |
2015-01 | Piperazine Analogs of Naphthyridine‐3‐carboxamides and Indole‐2‐carboxamides: Novel 5‐HT3 Receptor Antagonists with Antidepressant‐Like Activity | Mahesh, R. |
2014-07 | Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations | Mahesh, R. |
2017-02 | Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice | Mahesh, R. |
2005-06 | Microwave-assisted solvent-free synthesis of 3-[(4-substituted piperazin-1-yl)alkyl] imidazo[2,1-b][1,3]benzothiazol-2(3H)-ones as serotonin3 (5-HT3) receptor antagonists | Mahesh, R. |
Collection's Items (Sorted by Submit Date in Descending order): 1 to 20 of 337